ロード中...
Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
BACKGROUND: For patients with MS, medication switches increase the risk of disease reactivation. OBJECTIVE: Compare discontinuation rates due to treatment failure or side effects between teriflunomide and dimethyl fumarate, and investigate clinical variables affecting discontinuation rates. METHODS:...
保存先:
| 出版年: | Mult Scler J Exp Transl Clin |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8209840/ https://ncbi.nlm.nih.gov/pubmed/34188949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20552173211022027 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|